Defining precision post-polypectomy surveillance intervals is essential to optimize the balance between colonoscopy resource utilization and colorectal cancer (CRC) risk reduction within population-based fecal immunochemical test (FIT) screening programs. We sought to develop fecal hemoglobin concentration (f-Hb)-guided surveillance intervals and integrated into the existing surveillance framework.
Gastroenterology (AGA) published a clinical update in Research Highlights on 01 Apr 2026.
The item focuses on Fecal Hemoglobin-Guided Precision Post-polypectomy Surveillance within the Current Framework: A Four-Million-Participant FIT-based Screening Study.
Review the original article for the full source wording and details.